Recent developments in NMR spectroscopy have created two complementary categories of analysis for drug discovery processes. The first category includes techniques for obtaining high-resolution (especially H-1) NMR spectra of compounds still bound to solid-phase synthesis resins. The second category includes an automated high-throughput spectroscopy technique for acquiring high-resolution NMR spectra of liquids, directly sampled from microtiter plates, in a 'tubeless' mode, without the use of expensive deuterated solvents. This review summarizes these recent developments.